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Abstract 
 
The concept of an “innovation system” has become used increasingly in current science 
policy discourse as a metaphor to indicate the need for a much wider perspective on relevant 
decision-making procedures than has been the case in the past. This paper explores its use 
from the standpoint of the behaviour of an international agricultural research institute located 
in Africa and focused on two vector-borne livestock diseases, trypanosomiasis and theileriosis 
which form case studies for this paper. The paper argues that adopting an innovation systems 
perspective could open up new possibilities for research institutes of this type with impacts on 
both socio-economic development and scientific quality that are likely to be positive. 
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I Introduction 
 
The concept of an “innovation system” has become used increasingly in current science 
policy discourse as a kind of metaphor to indicate the need for a much wider perspective on 
relevant decision-making procedures than has been the case in the past5. Its particular use in 
agricultural research policy discussion is even more recent. For example it is increasingly 
difficult to regard publicly funded agricultural science as the only source of crop yield 
improvements and thus, international food security and social well being. Instead the research 
agenda has expanded to include issues of continued (and worsening) poverty, environmental 
sustainability, private sector activity, the complementary roles of non-governmental 
organisations (NGOs) and community-based organisations (CBOs), the importance of farmer 
knowledge, the growth of relevant agribusiness and changing (national and global) 
macroeconomic conditions. In short the agenda for agricultural science has arguably become 
much more complex and multidimensional. In particular it is about building up knowledge on 
how to integrate agricultural science better with client need and complementary capabilities, 
especially with relevance to poor rural communities. 
 
In short modern literature shows that the agenda for agricultural research has changed 
dramatically from the days of the Green Revolution, and with it the demands on relevant 
organisations. It is this new complex agenda that has created the need for a fresh look at 
science policy analysis for agriculture. Arguably agricultural R&D can no longer be left on its 
own to meet the new demands of the 21st century using the old institutional methodologies. In 
turn this means new types of relationship with other stakeholders and new types of capacity 
on the part of scientific institutions and organisations. This does not mean any reduction in the 
quality of the science. Rather the reverse in fact, as a UK Parliamentary Select Committee 
has pointed out in a recent report6. It implies that scientists and the organisations, in which 
they work, need to improve their capacities to undertake quality science. But to do this they 
                                                 
5 See for example Biggs, S.D., (1990), Hall et al (2000, 2001, 2003, 2004), Clark et al (2003), Juma C and Lee Yee-
Cheong (2005). 
6 See DFID (2004) 
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also must become more aware of the wider context of their research and how this can inform 
the nature and purpose of what they are trying to do. 
 
At the same time there is no clear understanding of the interdisciplinary issues involved, 
mainly because most stakeholder groups and individuals have been trained in ways that give 
emphasis to a narrow disciplinary focus and a reductionist approach to the conduct of 
research programmes. They are aware of the complexity of course, but often have difficulty 
translating this, in their minds and actions, to appropriate change. Hence at one level many 
scientists for example appear to accept that an “innovation systems” approach may be a 
useful way forward in agricultural research planning. But at another level they are at the same 
time not quite sure how to implement this as a set of practical projects. And the prevailing fear 
is that scientific quality may thereby be compromised.  This paper should be seen as a 
contribution in this respect. It argues that far from compromising scientific research the 
adoption of an innovation systems approach could actually add value to such research in both 
a cognitive and an applications sense. And in so doing the role and purpose of international 
bodies like the International Livestock Research Institute (ILRI) can be enhanced and 
expanded. 
 
Section II explores two cases on particular relevance to livelihoods in east Africa, and of 
particular relevance to the evolution of ILRI; one deals with the issue of theileriosis [East 
coast fever (ECF)] the other with trypanosomiasis in cattle. In the former case there have 
been two basic prophylactic approaches. One is the so-called Infection and Treatment (ITM) 
method of preventing the disease while the other is the attempt to develop a molecular 
vaccine that would have similar results. ILRI scientists have been intimately involved in the 
development of both approaches although in the case of ITM, ILRAD (one of the progenitor 
institutions of ILRI) relied heavily on the original discovery and development work done at the 
East Africa Veterinary Research Organisation (EAVRO) in its laboratory at Muguga in the late 
1960s; to date the ITM method has proved expensive and difficult to manage (although 
versions have been adapted and applied extensively in Tanzania and Zambia), whilst the new 
vaccine is still very much under development. Thus there has been limited impact on rural 
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livelihoods and poverty reduction so far. To date prevention is still primarily carried out by 
dipping cattle in a bath of acaracides designed to kill off the vector (the tick) that transmits the 
pathogen. In the case of trypanosomiasis the original aim of developing a vaccine has now 
been put aside (because of the complexity of the science) and resources are now 
concentrated on diagnosis, molecular characterisation and factors that determine 
trypanotolerance in cattle. The cases raise some interesting questions about how taking an 
innovation systems approach might have improved (and could still improve) the focus and 
effectiveness of research. 
 
Section III expands the discussion to what all this might mean for the organisation more 
widely. It suggests that ILRI might usefully engage more directly with a wider variety of 
stakeholder groups who have relevance to the associated “supply chain”. In particular it 
suggests that this engagement should take place at all stages from the original research 
strategy and design of proposals, the conduct of the research, testing of candidate protocols, 
formulation of medicines right through to final production, marketing and follow-up. It also 
reflects briefly on what this might mean for capacity building both within the organisation and 
in related bodies. Section IV summarises the paper and presents concluding remarks. To 
some extent these are speculative and should be subject to discussion and debate. But 
enough will be said to indicate that a general move in an innovation systems direction could 
pay rich dividends to research bodies such as ILRI7 and perhaps to agricultural science in the 
service of development more generally.  
 
II Case Studies 
 
In 1973, a Memorandum of Agreement was signed between the Government of Kenya and 
the Rockefeller Foundation (acting on behalf of the Consultative Group for International 
Agricultural Research [CGIAR]) for the establishment of one of the forerunners of ILRI,8 
                                                 
7 In fact it has to be said that ILRI under its new Director General has already taken steps in precisely this direction 
through he creation of a specially designated innovation systems team. 
8 The other is the International Livestock Centre for Africa (ILCA). The two bodies were merged in 1994. 
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ILRAD, as an international and autonomous, non-profit organisation. According to this 
agreement: 
“(t)he purpose of the Laboratory will be to serve as a world centre for research 
on ways and means of conquering, as quickly as possible, major animal 
diseases which seriously limit livestock industries in Africa and in many other 
parts of the world. The Laboratory will concentrate initially on intensive research 
concerning the immunological and related aspects of controlling trypanosomiasis 
and theileriosis (mainly East coast fever). It may, however, eventually extend its 
research to other serious animal disease problems for which its facilities and 
expertise are appropriate…In carrying forward its program, the Laboratory will 
develop close linkages with governmental and regional organisations 
undertaking research on the same or related disease problems” (ILRAD 1973; 
p.2). 
ILRAD was, therefore, set up as a laboratory-based scientific research institute with a global 
mandate to develop immunological solutions (mainly vaccines) to theileriosis and 
trypanosomiasis. In practice, as a result of the distribution and effects of the diseases, ILRAD 
would focus on Africa.9 
 
a. Trypanosomiasis Research and Development 
 
Trypanosomiasis is caused by unicellular protozoan parasites, termed trypanosomes, which 
propagate in the blood and tissue fluids of their hosts. Pathogenic species of Trypanosoma 
occur in Africa, Asia, Latin America and the Middle East, and infect among others man, cattle, 
sheep, goats and water buffalo. Some species of trypanosomes also cause sleeping sickness 
in humans. The susceptibility of host species differs – the disease can be either acute or 
chronic. Trypanosomiasis is frequently fatal in highly susceptible animals (such as Bos 
indicus Zebu cattle, and some exotic breeds), while in more resistant ones (including N’Dama 
cattle, a west African Bos taurus breed), the disease results in decreased productivity. 
                                                 
9 It should also be noted that the overall goal of the CGIAR at the time was to focus first world science and capacity 
on third world problems that were unique and important but would not attract attention of first world research or 
industry. 
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Symptoms of trypanosomiasis include sporadic periods of fever, wasting, enlargement of 
lymph nodes, anaemia, infertility and immune dysfunction. The major trypanosome species 
that infect animals in Africa are Trypanosoma congolese and Trypanosoma vivax. These are 
mainly transmitted by tsetse flies, although non-tsetse transmitted forms of trypanosomiasis 
also occur in Africa and South America. 
 
Trypanosomes assume different morphologies during their lifecycles in hosts and vectors 
(tsetse flies). They expose a variable surface glycoprotein coat on their outer layer when in 
the bloodstream of the host. This coat is lost once the parasite is ingested by a tsetse fly. The 
trypanosomes migrate to the salivary glands of the flies, where a new coat begins to develop. 
They now take on a non-dividing, coated metacyclic form. Upon feeding on another animal, 
the tsetse fly transmits these metacyclic forms into its skin. The trypanosome begins to 
acquire characteristics of a bloodstream form, and eventually enters the bloodstream. Thus, 
variable surface glycoproteins are present in both the bloodstream and metacyclic forms of 
trypanosomes. 
 
Once in the bloodstream, the trypanosomes begin to divide, and trigger an immune response 
from the host – antibodies are produced against the surface glycoprotein coats (essentially, 
‘the antigen face’) of the parasites. The trypanosomes have developed a survival strategy to 
avoid destruction by the host immune system. Trypanosome infection occurs as successive 
waves of parasites (known as parasitaemic waves) appearing in the blood and tissue spaces 
of the host. The host mounts an immune response to the repertoire of antigens (variable 
surface glycoprotein coats) present in each wave. By the time this immune response has 
occurred, some trypanosomes have altered their ‘antigenic faces’ – these will initiate the next 
wave of trypanosome infection, for which the host immune system is not prepared. This 
trypanosome survival technique is referred to as antigenic variation. It is a pre-programmed 
defence mechanism, which occurs in the absence of an antibody challenge, and is therefore 
not triggered by host immune pressure. 
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For decades, trypanosomiasis control has been attempted mainly through two routes – vector 
(tsetse fly) control and  trypanocide drugs. The former has involved a range of approaches, 
from tsetse habitat clearings and the use of impregnated traps, to the widespread application 
of insecticides and the use of the sterile male technique. Indeed in the early to mid 1980s 
according to one authoritative source “the days of tsetse seemed numbered”.10  Large scale 
spraying at ground and aerial levels had all but eliminated tsetse from large areas of east, 
west and southern parts of Africa that had previously been infested. This had given enormous 
benefit to livestock owners many of whom were poor farmers. In addition a range of newer 
technologies such as odour-baited targets and pyrethroid-treated cattle seemed to indicate 
that the problem was showing every sign of getting under permanent control.11 According to 
Torr et al, however, what seemed a promising research trajectory began to fall apart due to 
changing donor priorities and research policy positions. This combined with general economic 
decline in these countries meant that considerable ground was lost. It was in this context that 
ILRAD embarked on a biological solution to the trypanosomiasis problem in the early 1980s, 
namely the discovery of a vaccine. But as outlined above the development of such a vaccine 
was hampered due to antigenic variation and vaccine research efforts effectively ended at 
ILRI approximately five years ago. The focus of trypanosomiasis research at ILRI has shifted 
to the genetic characterization of trypanotolerant cattle.12 
 
b. East Coast Fever Vaccine Development 
 
Theileriosis refers to a complex of diseases caused by protozoan parasites from the genus 
Theileria. These parasites invade and propagate in the cells of the immune and 
haematopoietic (blood cell producing) systems of their hosts, mainly cattle. As in the case of 
trypanosomiasis, susceptibility to the disease differs amongst breeds – in highly susceptible, 
imported and more productive breeds, the disease is acute and frequently fatal (within three 
to four weeks of infection). Even in more resistant breeds, lower productivity follows recovery 
                                                 
10 See Torr et al (2005) p. 1. 
11 And in the same paper Torr et al argue that cheap mechanisms for tsetse control have now been refined to a 
stage that were they carefully applied, trypanosomiasis could well be effectively if not completely eliminated. 
12 Sources: ILRAD Annual Scientific Reports 1989-1994; ILRAD Annual Reports 1980-1993; ILRAD Strategic Plan 
1994-2003; ILRI Annual Reports 1995-2003; Discussions with Dr. Duncan Mwangi 
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from an infection. Symptoms include fever, lethargy, enlargement of the lymph nodes, 
difficulty in breathing and wasting. In Eastern and Central Africa the most important species is 
Theileria parva, which is transmitted by the brown ear tick, and which causes East Coast 
fever in cattle. The parasite is closely related to the causative agent of malaria in humans.  
 
Similar to trypanosomes, the T. parva parasite exists in different morphological states during 
the course of infection. The parasite is transmitted from a tick to a host in the sporozoite form, 
which directly infects the host’s white blood cells. The parasite develops into a schizont form, 
which transforms the white blood cells, causing them to continuously divide. The schizont 
essentially integrates itself into the cell division cycle of the host, and the effect is comparable 
to leukaemia. The maturation of the schizont into the merozoite stage causes cell rupture. 
These parasite forms infect red blood cells where they develop into the piroplasm stage. The 
piroplast forms of the parasite are picked up by a tick when feeding on a carrier host. Once in 
the tick, the parasite undergoes sexual reproduction, and development into a sporozoite, 
which is now distinct from the parasite it acquired while feeding 
 
Control of ECF has relied on the application of acaracides against ticks. In high-risk areas, 
cattle have been sprayed with, or dipped in, acaracides on a frequent basis. However, this is 
expensive, and tick populations have been shown to develop resistance to available 
chemicals. Pasture management has also proved to be effective, but small-scale livestock 
keepers often lack the resources required to implement this. Chemotherapeutic drugs have 
also been developed (napthoquinones), but these are expensive. Furthermore, infected 
animals must be treated early in order to fully recover. The most widely used approach 
remains the ‘infection and treatment method’ (ITM) of immunisation, described below. 
 
The prospects of a vaccine against ECF were initially encouraged with the discovery that an 
episode of theileriosis in an animal led to immunity. Subsequently, however, distinct strains of 
T. parva were found, and it was established that broad protection could only follow exposure 
to a variety of strains. This obstacle was overcome when it was elucidated that exposure to a 
combination of three different strains appeared to provide a broad immunity, and when it 
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became possible to harvest sporozoite forms of the parasite from ticks. This became the 
basis of the live vaccine used in ITM. Different strains of sporozoites extracted from infected 
ticks were injected into animals, and the animals were simultaneously treated with long-acting 
tetracycline antibiotics. While preventing full-blown clinical manifestations, the immunized 
animals occasionally show mild and transient symptoms of the disease. ITM, although widely 
implemented, has several shortcomings. It requires a cold chain facility to maintain the 
sporozoites alive, antibiotics, and expertise to monitor animals after treatment. These factors 
contribute to the high costs of ITM. Additionally, there is the risk of the live suspension being 
contaminated by other material from the tick. Furthermore, immunized animals become 
carriers of the parasite, and can potentially infect ticks and spread theileriosis. ILRAD initially, 
and ILRI subsequently, have been involved in the quality control aspects of ITM stocks. 
 
However, since the early 1980s ILRAD’s and ILRI’s activities in East Coast fever have mainly 
been focused on the development of alternative vaccines. The targets have been envisaged 
as both the sporozoite and schizont forms of the parasite. ILRI is currently developing a 
recombinant vaccine based on the antigens exposed by these forms. An anti-sporozoite 
vaccine has already been developed, based on the p67 protein (antigen) of the sporozoite to 
which the host immune system responds. Eight candidate schizont antigens have been 
identified to date, of which six are under closer focus. Ultimately, ILRI (with its extensive 
range of partners on this project) aims to develop a combination vaccine consisting of specific 
antigens of the sporozoite and schizont forms.13 Although it has to be said that the biology of 
the parasite has proved much more complex that initially assumed and it is proving harder to 
satisfy donor demands in this respect. 
 
IV Implications for Institutional Policy 
 
What then does this discussion tell us about research policy for an organisation like ILRI? We 
have suggested that an important analytical approach in this respect is that of the “innovation 
system.” This may be defined as the network of agents whose interactions determine the 
                                                 
13 Sources: ILRAD Annual Scientific Reports 1989-1994; ILRAD Annual Reports 1980-1993; ILRAD Strategic Plan 
1994-2003; ILRI Annual Reports 1995-2003; Discussions with Dr. Duncan Mwangi 
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innovative impact of knowledge interventions including those associated with scientific 
research. The concept is now used as a kind of shorthand for the network of inter-
organisational linkages that apparently successful countries have built up as a support system 
for economic production across the board. In this sense it has been explicitly recognised that 
economic creativity is actually about the quality of "technology linkages" and "knowledge 
flows" amongst and between economic agents. Where the interactions are dynamic and 
progressive great innovative strides are often made. Conversely where systemic components 
are compartmentalised and isolated from each other, the result is often that relevant research 
bodies are not at all productive. In extreme cases they have ceased to provide any innovative 
output at all. Put another way the key property of a system of innovation is therefore not so 
much its component parts, or nodes, but rather how it performs as a dynamic whole. 
 
But this still leaves the question how in practice does a research body like ILRI amend its 
institutional structure to take advantage of such an approach? Perhaps the best way of 
approaching this question is through looking through the lens of a “production” or “supply” 
chain since this automatically captures the totality of the system under consideration and by 
extension the relevant stakeholder groups. In general a supply chain looks something like that 
outlined in Figure 1.14 However, in reality it is immediately obvious that such a chain can 
never be linear since to be effective it must accommodate feedback of information (and 
resources) and therefore provide opportunities for learning and change. In fact what is 
commonly called a supply chain is in reality a system of interaction among key “nodes” and it 
is how collectively such nodes interact that determines the effectiveness of the system as a 
whole. Or in the case of a new technology how effective it is as an “innovation system”. Clark 
et al (2005) show how this worked in the case of the introduction of new transportation 
technology in Himachal Pradesh, India. Here while the original supply chain (i.e. the 
production and sale of tomatoes) looks fairly simple, when translated into innovation terms it 
becomes much more complex as may be seen in Figure 2. 
 
                                                 
14 Drawn from Clark et al (2005) which deals with the introduction of the treadle pump in Bangladesh and India. 
[“Mistris” are well-diggers who played a key role in the development of this technology] 
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In the case of research interventions (e.g. for interventions that may require bench science) 
the chain (or system) might be more like that outlined in Figure 3. In fact the chain outlined in 
red really acts more as a sort of “backbone” to a system of considerable complexity. Here the 
translation of resources into products that have value is subject to the informational impact of 
a wide range of activities only some of which are formally “scientific”. Government regulation, 
for example, sets boundaries as to what innovative interventions are permissible. NGOs of 
different types will usually possess tacit knowledge regarding the effectiveness and 
acceptability of new technologies, as often will be the case with the private sector. Public 
sector agencies will usually be in similar positions. In effect the simple “supply chain” sits in 
the middle of an “informational cloud” with properties analogous to those of an electro-
magnetic field.15 The problem though is how to manage these potential informational flows to 
maximise developmental opportunity. A further complication is that many of these different 
agencies may have interests that conflict and may resist interventions where they feel they 
might lose resources or power. 
 
What implications does this have for the management of research in particular and science 
policy more generally? Returning to the case study discussion of trypanosomiasis in the 
previous section the decision was taken in the early 1990s to abandon vaccine research 
because despite nearly 15 years of effort the likelihood of getting to a viable vaccine was felt 
to be minimal. The tsetse fly continues to be a scourge but, as we have said, there are other 
methods of dealing with trypanosomiasis in cattle, for example the use of traps and targets 
and bush clearing. Much of the research for this had produced good quality science 
throughout Africa but ILRAD did not ever really engage with it as a “research trajectory”. 
 
Within ILRI itself science continues to play a role but in the more limited sense of diagnostic 
research and research into trypanotolerance in cattle. Of course the question still remains as 
to why these other research trajectories were not given more emphasis in the early days 
since despite the fact that ILRAD (the predecessor of ILRI) established itself as a centre of 
                                                 
15 This notion of making an analogy with electro-magnetism in physics was first put forward in Clark and Juma 
(1992). The idea is to capture informational influences on socio-economic activity that have yet to be fully 
determined. See also Clark (2002) 
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bovine immunology, arguably it could still have been proactive in other senses. At the same 
time it must be said that the knowledge generated about antigenic variation in trypanosomes 
has led to an increased understanding of their basic biology, which, although it has 
highlighted the complexity and difficulty of developing a conventional vaccine, has identified 
alternative options. Similarly, the knowledge generated in the field about alternative methods 
to control trypanosomes has led to increased emphasis on research into drug resistance and 
the genetic basis of trypanotolerance.  
 
The case of ECF is rather more complex16. As mentioned above the ITM method was actually 
“invented” not by ILRAD but by a UNDP/FAO project at the East Africa Veterinary Research 
Association (EAVRO) in its laboratory at Muguga in the late 1960s with the aid of 
considerable UNDP/FAO funds. In fact ILRAD was only established in 1974 and did not begin 
serious research until some years later, when as an organisation it relied on expertise and 
unique parasite material at EAVRO. Early testing of the EAVRO “Muguga cocktail” was 
carried out in the field but mainly in Malawi, Uganda and Tanzania. Testing was not permitted 
in Kenya where it had been prohibited because of the inclusion of a parasite of Tanzanian 
origin that might induce carriers of the disease. Also there was a probability that dipping 
frequency would be reduced requiring changes in the Cleansing Act and undermining the 
opportunities to monitor cattle for other diseases when gathered for dipping.17  
 
The ‘cocktail’ was finally approved for limited use in Kenya in Maasai cattle in the last two 
years. Other countries, particularly Zambia with Belgian support, have continued to conduct 
live vaccine research, testing and production. In the intervening period live vaccines have 
been produced and used in Zambia and Zimbabwe, and a centre was established in Malawi 
for tick-borne vaccine research and production18. In addition there are now a range of 
therapeutic products on the market based on earlier research in UK, Germany and at Muguga 
                                                 
16 We are grateful to Dr T Dolan for his insights into the history and present status of ITM technology. These stem 
from his close association with this type of research since the mid 1970s. 
17 However, extensive testing of ITM was conducted in Kenya by UK supported projects with Kenyan counterparts 
from 1978 until 2000 extending the original FAO funded work, using locally isolated stocks; ILRAD conducted trials at 
the Kenya coast in the early 1980s with a coastal stock, Marikebuni, that was later tested in many parts of Kenya and 
adopted as the national immunizing stock. 
18 Although that centre ceased to be capable of large scale vaccine production as early as 1992 (personal interview). 
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and produced by international companies. Other reasons why vaccination was slow to be 
adopted in Kenya may have been the vested interests on the part of either veterinary 
authorities and/or acaracide manufacturers. And it has been suggested that one reason for 
the recent relaxation of prohibition in Kenya is the increasing problem of acaracide resistance 
in the tick population.  Arguably this has made the need for alternative solutions much more 
pressing. A final argument concerns the high costs involved in production and delivery, 
though these seem nowadays to be smaller than they once were. 
 
In fact ILRAD, in its initial mandate, made the strategic decision to look for an immunological 
solution to the ECF problem. From that point on the organisation saw itself as a high quality 
centre for research in bovine immunology with the ultimate objective of discovering vaccines 
for both cattle diseases through molecular research into the biology of the problem. ITM 
research continued but gradually gave way to the alternative approach until now it plays 
almost no part in ILRI activity. Hence it is apparent that there were (and still are) three prime 
mechanisms for dealing with the disease (ECF). In practice ILRAD took the view that the 
molecular ECF vaccine should be the preferred route. This may have been due to problems 
associated with the complexity and the expense associated with the ITM method. At the time 
of the early decision in the 1980s it seems reasonable to suggest that existing organisations 
would have had trouble actually testing and delivering this crude vaccine no matter how 
successful it had been in early trials.19 Conversely the prospects for a science-based vaccine 
must have seemed promising at the time.20  
 
However, as the new millennium has arrived the issue no longer seems so clear cut. The 
biology of ECF is now recognised as much more complex than initially expected and donors 
funding this research are inevitably wondering whether the expense will ever pay off in 
practical terms for the poor farmer, no matter how good the research is in purely scientific 
terms (although there is evidence that the project is building other kinds of research and 
                                                 
19At the time of setting up ILRAD, the countries of the region looked to it for the next generation of vaccines and, as 
molecular techniques for parasite characterisation were developed, they offered tools with which ITM strains could be 
better defined and compared. The cost of isolating, defining and producing national strains make it difficult for 
countries to adopt the control measure and most national programmes have been sustained through donor support-- 
UK in Kenya, FAO and the Netherlands in Tanzania now and Denmark in the past, and Belgium in Zambia.  For a 
useful discussion of these issues see Musisi and Dolan (1999). See especially pp 133-136. 
20 Although the 3rd EPMR in 1992 recommended only a further 5 years research on ECF vaccine research. 
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innovative capacity, cf. Smith, 2005). There is some evidence (interview data) that the 
fallback remedy (dipping the cattle) is becoming less effective due to growing acaricide 
resistance in the ticks. In addition it may very well be that better capacity now exists for ITM 
delivery because of institutional learning, improved infrastructure and possible private sector 
investment. It is here perhaps that an innovation systems analysis can play a decision-making 
role since by focusing on the wider context it allows for a more objective view of how to 
proceed. Thus the diagrams reveal the following generic properties: 
 
1. Formal research institutes are only one knowledge source among many. Others will 
certainly have a wide range of potential knowledge although much of this may only be 
tacit. 
2. Hence all actors (stakeholders) in the system are potentially nodes of a system that 
interact both informationally and economically 
3. Thinking in innovation systems terms enables you to map out options for creating 
coherence among the wider variety of actors 
4. It allows for more inclusive decision-making procedures on research projects 
5. It also provides guidelines for necessary institutional reform 
6. It extends the notion of “capacity building” beyond merely formal training 
7. It emphasises the importance of partnerships and continuous learning 
 
Returning to Figure 3 it is clear that ILRI research is inevitably embedded in a highly complex 
set of stakeholder interests. In the early days (i.e. from 1980 on) the organisation (at that time 
ILRAD) took the view that its major role was one of placing the bulk of its resources firmly 
behind the search for molecular vaccines. In a sense this became the central thrust, one that 
fitted well into a CG ethos that focused on the great importance of strategic science in solving 
the world’s food problems although why alternative scientific approaches were not given 
greater consideration at that time raises interesting questions of scientific management and 
political economy. Also though other stakeholder interests were present these appear to have 
played little or no role in such a specifically defined and science-led strategy. But as outlined 
in Section II time has gone on and the wider context has changed (partly, it is true, because of 
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the merger between ILRAD and ILCA in 1995).  Nowadays it is probably no longer possible 
for ILRI to function in an exclusively science-led mode which leaves it in a difficult position as 
a research organisation. How should it re-position itself to continue to make a contribution? 
 
It is our view that scientific research is clearly still of fundamental importance in dealing with a 
variety of livestock diseases that continue to plague the poor farmer in this part of the world. 
And therefore it is also clear that a research institute like ILRI should continue to play a pivotal 
role in technology development particularly where the necessary interventions are science-
based. From an innovation systems perspective, however, the difference would lie in its need 
to act also as a “knowledge facilitator” in the wider system of animal health resolution. It might 
for example develop a set of ITM projects that consisted of a consortium of stakeholder 
groups (led by ILRI) with a set of objectives that were ultimately developmental. Research 
needs could be anticipated to some extent but would also depend upon the evolution of the 
projects themselves. ILRI’s capacity to play such a wider role would also have to be 
developed. 
 
V Concluding Remarks 
 
We began this discussion paper by suggesting that the agenda for agricultural research has 
changed markedly from that obtaining in the days of the Green Revolution. One upshot of this 
is that scientific research bodies like those of the CG system are under increasing pressure to 
modify their ways of working. This much is already widely recognised in relevant policy 
circles. Indeed, ILRI is beginning to acknowledge some of this new thinking regarding 
knowledge: 
“ILRI’s strategy … reflect[s] a changing approach to international public good 
(IPG) research, particularly as it relates to poverty reduction. This approach 
acknowledges that a simple pipeline of technology transfer from researcher to 
the poor does not adequately respond to the complexities and dynamic changes 
faced by poor livestock keepers. These need to be addressed by an array of 
disciplines and expertise, through mechanisms that recognise and respond to 
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demand and with institutional support for learning and information sharing 
between partners.” (ILRI 2004; p. 108). 
The problem is really one of how to proceed. It is in this context that we have cited the cases 
of ECF and trypanosomiasis. Both have been central to ILRI historically, both illustrate the 
complexities of science-based technology development, and in both cases adopting an 
innovation systems perspective might have modified research trajectories. Indeed, elements 
of the current ECF vaccine research display an innovation systems approach. However it is 
not our intention to use these cases to criticise the organisation ex post as it were. On the 
contrary ILRAD (as it then was) probably behaved perfectly naturally given the culture of its 
time. A pessimistic view would be that the history of research into the science of this type of 
disease control has shown both the immense complexity of the problem and the 
underestimation of this complexity in early research approaches. Moreover the great 
reduction of funding for this type of strategic scientific research may now mean that bodies 
like ILRI no longer have the rationale that was envisaged at the time of their creation. 
 
A more optimistic view is that we now have a better idea of the role of knowledge in socio-
economic development and that ILRI could benefit from this knowledge in its future research 
planning. While the lack of core funding may preclude the type of research that will lead to 
major breakthroughs ILRI could begin to play more of a scientific brokerage role in which it 
acts as a sort of central scientific resource dealing with strategic scientific issues affecting 
animal health and livestock production in Africa. A similar function might also be adopted by 
other CG centres. However, as has often been pointed out there are still tensions within 
relevant science communities regarding the professional status of science policy concerns. 
The basic issue is the familiar one of “mode 1” versus “mode 2”.21 Research managers worry 
that bench scientists will become distracted from their research, which will suffer as a 
consequence. Some still do not yet accept that the agenda for research has changed and 
wish to return to earlier Green Revolution mandates.  
 
                                                 
21 See Clark (2002) for an account relevant to international agricultural research. For the original source on this point 
see Gibbons (1994). Very crudely the distinction is as follows. “Mode 1” approaches (the traditional view) argue for a 
complete organisational separation between scientific research on the one hand and its practical application for 
economic and social welfare on the other. Conversely “Mode 2” approaches argue for institutional arrangements that 
build science policy concerns directly into the conduct of R&D. 
 17
The policy-making community is also torn. On the one hand it is used to treating the R&D 
system as a disinterested source of knowledge of relevance to sectoral ministries. On the 
other it has developed a view that many publicly financed R&D projects are an expensive 
drain on resources and are not having the impacts expected of them. The issue here is 
probably one of awareness raising. Evidence from industrial sector experience indicates that 
a focus on “innovation” rather than “science” requires fundamental institutional changes that 
have themselves to be innovated. Such changes mean experimenting with the unknown and 
are bound to lead to uncertainty. Nevertheless some movement in this direction is inevitable. 
It is our considered view that far from compromising science, there is every likelihood that 
science will re-establish itself as a central component in the achievement of the Millennium 
Development Goals. 
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Figure 1 Treadle Pump Supply Chain Source: Clark et al (2006). 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 2 Innovation System for Tomato Boxes; Source: Clark et al (2003). 
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Figure 3 ECF Supply Chain  
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